Heme Oxygenase 2 Genetic Variants Alter Hormonal and Metabolic Traits in Polycystic Ovary Syndrome

Overview

Journal Endocr Connect

Specialty Endocrinology

Date 2024 Jan 22

PMID 38251965

Authors

Xinyuan Zhang

Suiyan Li

Hongwei Liu

Huai Bai

Qingqing Liu

Chunyi Yang

Ping Fan

Affiliations

Soon will be listed here.

Abstract

Oxidative stress and metabolic disorders are involved in the pathogenesis of polycystic ovary syndrome (PCOS). Heme oxygenase 2 (HMOX2) plays a critical role in preserving heme metabolism as well as in modulating glycolipid metabolism, oxidative stress, and inflammation. This study examined the correlation between HMOX2 G554A (rs1051308) and A-42G (rs2270363) genetic variants with the risk of PCOS and assessed the effects of these genotypes on clinical, hormonal, metabolic, and oxidative stress indices using a case-control design that included 1014 patients with PCOS and 806 control participants. We found that the allelic and genotypic frequencies of the HMOX2 G554A and A-42G polymorphisms were comparable between the PCOS and control groups in Chinese women (P > 0.05). Nevertheless, it was discovered that patients with the AA or AG genotype of A-42G polymorphism had notably elevated levels of estradiol (E2), follicle-stimulating hormone (FSH), luteinizing hormone (LH), LH/FSH ratio, high-density lipoprotein cholesterol (HDL-C), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), apolipoprotein (apo)B, and/or apoB/apoA1 ratio than those with the GG genotypes (P < 0.05). Patients with the GG or AG genotype of G554A polymorphism had elevated serum levels of LH, FSH, E2, LH/FSH ratio, TC, HDL-C, LDL-C, apoB, and/or apoB/apoA1 ratio and lower 2-h glucose concentration compared with those with the AA genotype (P < 0.05). Our findings indicate a potential association between the genetic variants and endocrine abnormalities in the reproductive system and metabolic irregularities in glycolipid levels in patients, thus suggesting their potential role in the pathogenesis of PCOS.

References

Zhang R, Liu H, Bai H, Zhang Y, Liu Q, Guan L . Oxidative stress status in Chinese women with different clinical phenotypes of polycystic ovary syndrome. Clin Endocrinol (Oxf). 2016; 86(1):88-96. DOI: 10.1111/cen.13171. View

Kakoly N, Khomami M, Joham A, Cooray S, Misso M, Norman R . Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression. Hum Reprod Update. 2018; 24(4):455-467. DOI: 10.1093/humupd/dmy007. View

Sun S, Jiao M, Han C, Zhang Q, Shi W, Shi J . Causal Effects of Genetically Determined Metabolites on Risk of Polycystic Ovary Syndrome: A Mendelian Randomization Study. Front Endocrinol (Lausanne). 2020; 11:621. PMC: 7505923. DOI: 10.3389/fendo.2020.00621. View

Teede H, Tay C, Laven J, Dokras A, Moran L, Piltonen T . Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur J Endocrinol. 2023; 189(2):G43-G64. DOI: 10.1093/ejendo/lvad096. View

Fabries P, Drogou C, Sauvet F, Nespoulous O, Erkel M, Marchandot V . The polymorphism contributes to the carotid body chemoreflex in European sea-level residents by regulating hypoxic ventilatory responses. Front Med (Lausanne). 2022; 9:1000786. PMC: 9669423. DOI: 10.3389/fmed.2022.1000786. View

Prabhu B, Kanchamreddy S, Sharma A, Bhat S, Bhat P, Kabekkodu S . Conceptualization of functional single nucleotide polymorphisms of polycystic ovarian syndrome genes: an in silico approach. J Endocrinol Invest. 2021; 44(8):1783-1793. PMC: 8285346. DOI: 10.1007/s40618-021-01498-4. View

Zhu T, Goodarzi M . Causes and Consequences of Polycystic Ovary Syndrome: Insights From Mendelian Randomization. J Clin Endocrinol Metab. 2021; 107(3):e899-e911. PMC: 8852214. DOI: 10.1210/clinem/dgab757. View

Liu Q, Liu H, Bai H, Huang W, Zhang R, Tan J . Association of SOD2 A16V and PON2 S311C polymorphisms with polycystic ovary syndrome in Chinese women. J Endocrinol Invest. 2019; 42(8):909-921. DOI: 10.1007/s40618-018-0999-5. View

Fleischhacker A, Gunawan A, Kochert B, Liu L, Wales T, Borowy M . The heme-regulatory motifs of heme oxygenase-2 contribute to the transfer of heme to the catalytic site for degradation. J Biol Chem. 2020; 295(16):5177-5191. PMC: 7170523. DOI: 10.1074/jbc.RA120.012803. View

10.

Ayuso P, Martinez C, Lorenzo-Betancor O, Pastor P, Luengo A, Jimenez-Jimenez F . A polymorphism located at an ATG transcription start site of the heme oxygenase-2 gene is associated with classical Parkinson's disease. Pharmacogenet Genomics. 2011; 21(9):565-71. DOI: 10.1097/FPC.0b013e328348f729. View

11.

Escobar-Morreale H . Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018; 14(5):270-284. DOI: 10.1038/nrendo.2018.24. View

12.

Vanella L, Volti G, Guccione S, Rappazzo G, Salvo E, Pappalardo M . Heme oxygenase-2/adiponectin protein-protein interaction in metabolic syndrome. Biochem Biophys Res Commun. 2013; 432(4):606-11. PMC: 5553546. DOI: 10.1016/j.bbrc.2013.02.037. View

13.

Gao H, Meng J, Xing H, Nie S, Xu M, Zhang S . Association of heme oxygenase-1 with the risk of polycystic ovary syndrome in non-obese women. Hum Reprod. 2014; 29(5):1058-66. DOI: 10.1093/humrep/deu029. View

14.

Wang J, Li S, Li X, Liu J, Yang J, Li Y . Functional variant rs2270363 on 16p13.3 confers schizophrenia risk by regulating NMRAL1. Brain. 2022; 145(7):2569-2585. PMC: 9612800. DOI: 10.1093/brain/awac020. View

15.

Mancini A, Bruno C, Vergani E, dAbate C, Giacchi E, Silvestrini A . Oxidative Stress and Low-Grade Inflammation in Polycystic Ovary Syndrome: Controversies and New Insights. Int J Mol Sci. 2021; 22(4). PMC: 7915804. DOI: 10.3390/ijms22041667. View

16.

Stener-Victorin E, Deng Q . Epigenetic inheritance of polycystic ovary syndrome - challenges and opportunities for treatment. Nat Rev Endocrinol. 2021; 17(9):521-533. DOI: 10.1038/s41574-021-00517-x. View

17.

. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004; 81(1):19-25. DOI: 10.1016/j.fertnstert.2003.10.004. View

18.

Agundez J, Garcia-Martin E, Martinez C, Benito-Leon J, Millan-Pascual J, Diaz-Sanchez M . Heme Oxygenase-1 and 2 Common Genetic Variants and Risk for Multiple Sclerosis. Sci Rep. 2016; 6:20830. PMC: 4751624. DOI: 10.1038/srep20830. View

19.

Yao H, Peterson A, Li J, Xu H, Dennery P . Heme Oxygenase 1 and 2 Differentially Regulate Glucose Metabolism and Adipose Tissue Mitochondrial Respiration: Implications for Metabolic Dysregulation. Int J Mol Sci. 2020; 21(19). PMC: 7582259. DOI: 10.3390/ijms21197123. View

20.

Robert Y, Dubrulle F, Gaillandre L, Ardaens Y, Lemaitre L, Dewailly D . Ultrasound assessment of ovarian stroma hypertrophy in hyperandrogenism and ovulation disorders: visual analysis versus computerized quantification. Fertil Steril. 1995; 64(2):307-12. View